Skip to main content

Table 3 Long-term follow up results

From: Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers

Recurrence Group A
n (%)
Group B
n (%)
Group C
n (%)
P value
Local Recurrence 15 (21.7) 5 (8.6) 18 (34) 0.012
Median(range) disease free(months) 53.3(0.57-176) 33.78(6.8-139) 41.5(4.7-136) NS
Systemic recurrence 14 (20.3) 13(22.4) 18(33.9) NS (0.543)
5 year cancer-specific survival rate (49.3) (69.9) (38.8) 0. 14